Cresco Labs (CRLBF) Stock Price, News & Analysis

Company Overview

Cresco Labs Inc. is a vertically integrated cannabis company that cultivates, manufactures, distributes and sells cannabis products in the United States. Its operations include cannabis cultivation facilities, product manufacturing and wholesale distribution, as well as retail dispensaries operating under the Sunnyside brand.

The company offers a range of cannabis products, including flower, pre-rolls, vapes, concentrates, edibles and other wellness-oriented products. Its portfolio has included brands such as Cresco, High Supply, Good News, Wonder Wellness, Remedi and FloraCal Farms, with product availability varying by state and local regulations.

Founded in 2013 and headquartered in Chicago, Cresco Labs serves regulated cannabis markets through state-licensed operations. The company has established a presence in several U.S. states, including Illinois, Pennsylvania, Ohio, Florida, Maryland, Michigan, Massachusetts, New York, Arizona and California, although its operations and market footprint may change as regulations and licensing conditions evolve.

Key Stats

• Today's Range: $0.72 to $0.74
• 50-Day Range: $0.64 to $0.82
• 52-Week Range: $0.59 to $2.30
• Volume: 159,567 shs
• Average Volume: 442,363 shs
• Market Capitalization: $371.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Cresco Labs Stock Analysis - MarketRank™

Cresco Labs scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Cresco Labs has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cresco Labs are expected to grow in the coming year, from ($0.04) to ($0.02) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cresco Labs is -2.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cresco Labs is -2.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cresco Labs has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.23% of the float of Cresco Labs has been sold short.

Short Interest Ratio / Days to Cover

Cresco Labs has a short interest ratio ("days to cover") of 1.36, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cresco Labs has recently decreased by 18.66%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cresco Labs does not currently pay a dividend.

Dividend Growth

Cresco Labs does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

4 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cresco Labs insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.05% of the stock of Cresco Labs is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/15/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CRLBF
• CIK: 1832928
• Web: www.crescolabs.com
• Phone: 312-929-0993
• Fax: N/A
• Employees: 2,900
• Year Founded: 2013

Profitability

• EPS (Trailing Twelve Months): ($0.30)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$135.41 million
• Net Margins: -15.50%
• Pretax Margin: -15.92%
• Return on Equity: -7.53%
• Return on Assets: -1.68%

Debt

• Debt-to-Equity Ratio: 1.66
• Current Ratio: 1.78
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $655.85 million
• Price / Sales: 0.57
• Cash Flow: $0.04 per share
• Price / Cash Flow: 19.27
• Book Value: $0.50 per share
• Price / Book: 1.48

Miscellaneous

• Outstanding Shares: 502,760,000
• Free Float: N/A
• Market Cap: $371.99 million
• Optionable: Not Optionable
• Beta: 1.57